Masaru Baba
Impact in
- Endocrinology top 5%
- Infections and bacterial resistance
- Molecular Medicine top 10%
- Antibiotic Resistance in Bacteria
Papers in
- Epidemiology 10
- Liver Disease Diagnosis and Treatment 5
- Hepatitis B Virus Studies 3
- Surgery 7
- Helicobacter pylori-related gastroenterology studies 3
- Co-authors
- Hideki Araoka (12 shared papers)Akiko Yoneyama (9 shared papers)Issam Raad (1 shared paper)G P Bodey (1 shared paper)Shiro Suzuki (4 shared papers)Hisaki Nagai (4 shared papers)Nanao Kamada (1 shared paper)Hiroshi Hasegawa (1 shared paper)
- Journals
- PLoS ONE (2 papers)Clinical Infectious Diseases (2 papers)Scientific Reports (2 papers)Cancer Letters (1 paper)International Journal of Infectious Diseases (1 paper)
- Partner nations
- JapanUnited StatesSouth Korea
In The Last Decade
Masaru Baba
34 papers receiving 523 citations
Peers
Comparison fields: 5 of 62
- Endocrinology 101
- Molecular Medicine 46
- Emergency Medical Services 48
- Applied Microbiology and Biotechnology 14
- Hepatology 53
Countries citing papers authored by Masaru Baba
This map shows the geographic impact of Masaru Baba's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masaru Baba with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masaru Baba more than expected).
Fields of papers citing papers by Masaru Baba
This network shows the impact of papers produced by Masaru Baba. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masaru Baba. The network helps show where Masaru Baba may publish in the future.
Co-authors
The 25 scholars most cited alongside Masaru Baba, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 37 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 75 | |
| 2 | 1995 | 68 | |
| 3 | 1995 | 62 | |
| 4 | 2002 | 47 | |
| 5 | 2010 | 36 | |
| 6 | 2001 | 26 | |
| 7 | 2019 | 24 | |
| 8 | 2017 | 24 | |
| 9 | 2018 | 20 | |
| 10 | 2011 | 18 | |
| 11 | In vitro combination effects of aztreonam and aminoglycoside against multidrug-resistant Pseudomonas aeruginosa in Japan. | 2012 | 18 |
| 12 | 2017 | 16 | |
| 13 | 2009 | 16 | |
| 14 | 2012 | 16 | |
| 15 | 2022 | 15 | |
| 16 | 2000 | 9 | |
| 17 | 2004 | 8 | |
| 18 | 1994 | 7 | |
| 19 | 2019 | 6 | |
| 20 | 2018 | 5 |
About Masaru Baba
Masaru Baba is a scholar working on Epidemiology, Surgery, Hepatology, Infectious Diseases and Molecular Biology, having authored 37 papers that have together received 550 indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (5 papers), Hepatitis C virus research (4 papers), Antibiotic Resistance in Bacteria (4 papers), Hepatitis B Virus Studies (3 papers), Antibiotics Pharmacokinetics and Efficacy (3 papers), Helicobacter pylori-related gastroenterology studies (3 papers), Antibiotic Use and Resistance (3 papers) and RNA Research and Splicing (2 papers). The work is most often cited by research in Endocrinology (101 citations), Molecular Medicine (46 citations), Emergency Medical Services (48 citations), Applied Microbiology and Biotechnology (14 citations) and Hepatology (53 citations). Masaru Baba has collaborated with scholars based in Japan, United States and South Korea. Frequent co-authors include Hideki Araoka, Akiko Yoneyama, Issam Raad, G P Bodey, Shiro Suzuki, Hisaki Nagai, Nanao Kamada, Hiroshi Hasegawa, Noboru Konishi and Muneyoshi Kimura. Their work appears in journals such as PLoS ONE, Clinical Infectious Diseases, Scientific Reports, Cancer Letters and International Journal of Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.